Skip to main content
logo
Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.150
-0.130 (-3.96%)
Jul 31, 2026, 4:00 PM EDT - Market closed

Can-Fite BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
77862,4311,4962,5005,262
Market Cap Growth
-44.28%-67.69%62.54%-40.17%-52.48%27.47%
Enterprise Value
-1.59777.062,4241,4872,4925,243
Last Close Price
3.15600.004890.006600.0018390.0038700.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.811939.573607.262013.213086.736168.27
PB Ratio
1.29140.47447.26239.60559.09365.84
P/TBV Ratio
0.4688.32326.23225.24559.09248.04

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1918.663595.712001.263076.946145.98

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.000.000.00
Net Debt / Equity Ratio
-1.51-1.51-1.43-1.42-1.77-1.32
Net Debt / EBITDA Ratio
0.850.850.961.090.791.48
Net Debt / FCF Ratio
0.950.951.021.050.731.93
Asset Turnover
0.040.040.070.080.050.06
Quick Ratio
3.133.133.844.423.197.01
Current Ratio
3.463.464.384.903.667.35
Return on Equity (ROE)
-178.24%-178.24%-134.94%-142.49%-107.91%-123.34%
Return on Assets (ROA)
-106.79%-106.79%-85.09%-85.05%-68.36%-86.26%
Return on Capital Employed (ROCE)
-143.67%-143.67%-108.13%-111.12%-83.08%-99.64%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-126.97%-126.97%-70.22%-56.71%-47.49%-54.31%
Total Shareholder Return
-126.97%-126.97%-70.22%-56.71%-47.49%-54.31%
SEC Filings: 10-K · 10-Q